In a divisive ruling, the Supreme Court has upheld Tennessee's law banning gender-affirming care for minors, igniting fierce debates over youth rights and medical ethics. Advocates argue it violates equal protection, while supporters hail it as necessary for child safety.
The Trump administration's decision to revoke guidance requiring hospitals to provide emergency abortions raises serious concerns for women's health, especially in states with strict abortion bans. Advocates warn this could lead to dangerous consequences for pregnant women in medical emergencies.
Robert F. Kennedy Jr. canceled a critical $766 million contract with Moderna for a bird flu vaccine, raising concerns about public health and vaccine safety amidst a potential outbreak.
Pharma faces a daunting challenge as Trump takes bold steps to cut drug prices. With RFK Jr. praising the move, is bipartisanship on the horizon or will the industry fight back?
In a groundbreaking move, President Trump has issued an executive order aimed at ending the price discrimination faced by American consumers in the pharmaceutical market. This order seeks to ensure that Americans pay the same low prices for medications as those in other developed nations, addressing the long-standing issue of subsidizing global pharmaceutical profits.
President Trump unveils a groundbreaking executive order aimed at slashing U.S. drug prices by matching them to those in developed countries. Will this initiative reshape the pharmaceutical landscape and benefit American patients?
As Republicans clash over Medicaid cuts, Speaker Mike Johnson faces pressure from both moderates and hard-liners. Can he unite the party and push Trump's agenda through Congress? Explore the escalating tensions and implications for millions of Americans.
Republican Rep. Jeff Van Drew warns Trump that cuts to Medicaid could jeopardize the GOP's majority. As the House GOP votes on a budget framework, the implications for health coverage and the 2026 midterms loom large.
